Kevin Braeckmans

Kevin Braeckmans is a co-founder and CSO/CTO of Trince, a Belgian biotech company developing cell therapy manufacturing technology.

1 News mention

Overview

Kevin Braeckmans is a Full Professor at Ghent University and co-founded Trince with Stefaan Desmedt and Philip Mathuis. Trince is a Ghent University spin-off developing the LumiPore transfection platform, which uses laser exposure and photothermal nanoparticles to deliver molecules into cells. The company raised EUR 4M in a seed round from QBIC and Novalis Biotech in 2021.

Career history

  1. FounderTrince

In the news

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.